בטאלין תרפיוטיקס בע"מ

Betalin is developing a micro-pancreas to liberate diabetic patients from their daily insulin dependency. It responds to the patient’s blood glucose levels by releasing controlled therapeutic levels of insulin for at least a year.

Insulin dependent diabetes patients, Medical service providers.

Racheli Ofir - CEO & CTO

Racheli Ofir - CEO & CTO